Back to search
FDAFDA · Food and drugs·Recall number Z-0169-2013

MOSAIQ MOSAIQ is an image-enabled electronic medical record system (EMR) used for oncology workflow management. It lets users supply electronic patient charts and assemble care plans, order diagnostic tests, and prescribe medications. It also lets users import, view, annotate, manipulate, enhance, manage, and archive images.

Published November 7, 2012 · Recall initiated: September 18, 2012

Summary

FDA records medical device Class II recall Z-0169-2013, published November 7, 2012 and initiated September 18, 2012. Recalling firm: Elekta, Inc.; Status: Terminated; Reported quantity: 300; Lot: Version 2.00 to 2.41. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A patient was seriously mistreated after a user made and saved an inadvertent change to the definition of a treatment filed in MOSAIQ.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Elekta, Inc.
Distributor
Worldwide distribution: USA (nationwide) and country of Canada.
Lot
Version 2.00 to 2.41
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was MOSAIQ MOSAIQ is an image-enabled electronic medical record system (EMR) used for oncology workflow management. It lets users supply electronic patient charts and assemble care plans, order diagnostic tests, and prescribe medications. It also lets users import, view, annotate, manipulate, enhance, manage, and archive images. recalled?

Yes. FDA published recall Z-0169-2013 on November 7, 2012. Reported hazard: A patient was seriously mistreated after a user made and saved an inadvertent change to the definition of a treatment filed in MOSAIQ.

What should I do if I have this product?

Voluntary: Firm initiated · Letter